Collaborating on a Multi-Component intervention to increase Lung Cancer Screening uptake

合作开展多方面干预措施以提高肺癌筛查的采用率

基本信息

  • 批准号:
    10408362
  • 负责人:
  • 金额:
    $ 15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-04 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Abstract/Project Summary: NCCC is the only NCI-designated Comprehensive Cancer Center in the Northern New England region (i.e., VT, NH, ME). NCCC has a bi-state catchment area comprised of New Hampshire and Vermont that is impacted by high lung cancer incidence and mortality rates. The CDC-funded VT Cancer Plan for 2021-2025, while not final, will include a goal to increase lung cancer screening (LCS) uptake—as only 15% of eligible Vermonters were up-to-date with screening in 2017. VT’s cancer coalition, Vermonters Taking Action Against Cancer (VTAAC), convenes individuals and organizations from across VT (including NCCC and project partners the American Lung Association, Vermont Department of Health, and University of Vermont Medical Center) to help implement the Cancer Plan. VTAAC has an existing Task Force infrastructure to bring together partners focused on specific areas of the cancer plan—including an LCS Task Force. While this infrastructure has supported connections, networking, and cooperation among partners, VTAAC’s Steering Committee and NCCC would like to foster deeper, collaborative relationships in which partners—including NCCC—co-implement and co-evaluate projects. We will pilot an enhanced Task Force model with the LCS Task Force, building its capacity to truly collaborate on a shared project by providing funding for the lead organization, convening the group specifically for project collaboration, assessing the Task Force’s membership, and reviewing project evaluation results and jointly determining future directions for sustained collaboration. Drawing on The Community Guide’s robust evidence-base for interventions that effectively increase uptake of other cancer screenings, we will collaborate with the VTAAC LCS Task Force and its members to co-implement and co-evaluate a multicomponent intervention to increase LCS uptake while addressing known barriers to LCS in our catchment. The intervention will include: 1) an educational campaign to increase community demand for LCS; 2) transportation programs and streamlined appointment scheduling to increase community access; 3) and continuing education, provider reminders, and provider assessment/feedback to increase provider delivery of LCS referrals. The LCS Task Force will review the evaluation results and determine which components to sustain and scale with additional partners based on impact and feasibility. To further sustain our enhanced partnership and optimize the opportunities for collaboration, we will conduct a modified Delphi technique to seek consensus on the broader coalition’s top priorities, we will support the development of new Task Forces aligned with those priorities, and we will seek collaborative funding. To facilitate engagement of additional NCCC investigators with VTAAC, we will conduct an in-reach assessment of NCCC Cancer Population Science Research Program investigators’ areas of expertise, train them on community engagement principles, and match them with the appropriate VTAAC Task Forces.
摘要/项目摘要:NCCC是北部唯一指定的综合癌症中心 新英格兰地区(即VT,NH,我)。 NCCC拥有新罕布什尔州的双州集水区 以及受高肺癌发病率和死亡率影响的佛蒙特州。 CDC资助的VT癌 2021 - 2025年的计划虽然不是最终的,但仍将包括增加肺癌筛查(LCS)吸收的目标 - 仅仅是 2017年,有15%的合格佛蒙特人通过筛查是最新的。VT的癌症联盟,佛蒙特州 反对癌症的行动(VTAAC),召集了来自VT的个人和组织(包括NCCC和 项目合作伙伴美国肺部协会,佛蒙特州卫生系和佛蒙特大学 医疗中心)帮助实施癌症计划。 VTAAC拥有现有的工作组基础架构 合作伙伴聚焦于癌症计划的特定领域,包括LCS工作队。同时 基础架构支持合作伙伴之间的联系,网络和合作,VTAAC的转向 委员会和NCCC希望建立更深入的合作关系,其中包括 NCCC - 实施和共同评估项目。我们将使用LCS驾驶增强的工作队模型 特遣部队,通过为领先者提供资金来建立真正在共享项目上合作的能力 组织,专门用于项目合作的小组,评估工作队的 会员资格,并审查项目评估结果,并共同确定未来的指示 合作。利用社区指南的强大证据基础,以有效地进行干预措施 增加其他癌症筛查的吸收,我们将与VTAAC LCS特遣部队及其合作 成员共同实施和共同评估多组分干预措施以增加LCS的吸收,而 在我们的集水区中解决已知障碍。干预措施将包括:1)教育运动 增加社区对LCS的需求; 2)运输计划和简化的约会计划 增加社区访问权限; 3)和继续教育,提供者提醒和提供者 评估/反馈以增加提供者的LCS推荐。 LCS工作队将审查 评估结果并确定哪些组成部分可以维持和扩展与其他合作伙伴有关 影响和可行性。进一步维持我们增强的伙伴关系,并优化 合作,我们将进行修改的Delphi技术,以在更广泛的联盟的顶部寻求共识 优先事项,我们将支持与这些优先事项一致的新工作组的发展,我们将寻求 协作资金。为了促进其他NCCC调查人员与VTAAC的参与,我们将进行 NCCC癌症人群科学研究计划研究人员的领域的范围内评估 专业知识,培训他们有关社区参与原则,并与适当的VTAAC任务相匹配 力量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven D Leach其他文献

Steven D Leach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven D Leach', 18)}}的其他基金

Developing ATAC-array as a novel epigenetic biomarker to guide personalized therapy in pancreatic cancer
开发 ATAC 阵列作为新型表观遗传生物标志物来指导胰腺癌的个性化治疗
  • 批准号:
    10512502
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
Administrative supplement for Early Drug Development Opportunity Program (EDDOP)
早期药物开发机会计划 (EDDOP) 的行政补充
  • 批准号:
    10677500
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
P30 Administrative Supplement to Cancer Center Support Grant to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network.
P30 癌症中心支持补助金的行政补充,旨在通过国家外展网络的社区健康教育者加强 NCI 支持的社区外展能力。
  • 批准号:
    10370916
  • 财政年份:
    2021
  • 资助金额:
    $ 15万
  • 项目类别:
Community-led Action Research in Oncology: Pandemic-appropriate Radiotherapy Innovations Evaluated for LMICs
社区主导的肿瘤学行动研究:针对中低收入国家评估适合流行病的放射治疗创新
  • 批准号:
    10380931
  • 财政年份:
    2021
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9476973
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9922888
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9080884
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System
斑马鱼系统中人类胰腺癌基因的功能评估
  • 批准号:
    8464656
  • 财政年份:
    2013
  • 资助金额:
    $ 15万
  • 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
  • 批准号:
    8248212
  • 财政年份:
    2011
  • 资助金额:
    $ 15万
  • 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
  • 批准号:
    8095001
  • 财政年份:
    2011
  • 资助金额:
    $ 15万
  • 项目类别:

相似海外基金

2-Generation Interventions to Improve Cardiovascular Health in Indiana and Illinois Through Home Visiting (2-NOURISH)
通过家访改善印第安纳州和伊利诺伊州心血管健康的第二代干预措施 (2-NOURISH)
  • 批准号:
    10427796
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
利用基因组学表型簇改善肺纤维化分类
  • 批准号:
    10378511
  • 财政年份:
    2020
  • 资助金额:
    $ 15万
  • 项目类别:
Advancement of Clinical Referral to Physical Activity for Cardiometabolic Disease Prevention
临床转介体力活动预防心血管代谢疾病的进展
  • 批准号:
    10414033
  • 财政年份:
    2020
  • 资助金额:
    $ 15万
  • 项目类别:
Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
利用基因组学表型簇改善肺纤维化分类
  • 批准号:
    9892577
  • 财政年份:
    2020
  • 资助金额:
    $ 15万
  • 项目类别:
Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
利用基因组学表型簇改善肺纤维化分类
  • 批准号:
    10581653
  • 财政年份:
    2020
  • 资助金额:
    $ 15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了